Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-26
DOI
10.3389/fendo.2021.599586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERK/MAPK signalling pathway and tumorigenesis (Review)
- (2020) Yan‑Jun Guo et al. Experimental and Therapeutic Medicine
- Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
- (2020) Ufuk Degirmenci et al. Cells
- NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells
- (2020) Edina Erdős et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The NFκB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
- (2020) Irida Kastrati et al. MOLECULAR CANCER RESEARCH
- SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1
- (2020) Jun Zhou et al. OncoTargets and Therapy
- The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance
- (2020) Cristina P. R. Xavier et al. Cells
- Influence of plasma circulating exosomes obtained from obese women on tumorigenesis and tamoxifen resistance in MCF ‐7 cells
- (2020) Sahar Sadegh‐Nejadi et al. IUBMB LIFE
- A Role for Estrogen Receptor alpha36 in Cancer Progression
- (2020) Maria Teresa Pagano et al. Frontiers in Endocrinology
- Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer
- (2020) Elena-Georgiana Dobre et al. Cancers
- The role of estrogen receptor beta in breast cancer
- (2020) Yujing Zhou et al. Biomarker Research
- Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer
- (2020) Ji Hoon Oh et al. CANCER LETTERS
- Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A review
- (2019) Junjie Li et al. Cancer Medicine
- Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
- (2019) Aradhana Rani et al. Frontiers in Endocrinology
- The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer
- (2019) María Inés Diaz Bessone et al. Frontiers in Endocrinology
- Pathways to Endocrine Therapy Resistance in Breast Cancer
- (2019) Md. Moquitul Haque et al. Frontiers in Endocrinology
- Non-genomic Effects of Estrogen on Cell Homeostasis and Remodeling With Special Focus on Cardiac Ischemia/Reperfusion Injury
- (2019) Rossella Puglisi et al. Frontiers in Endocrinology
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
- (2018) Wei Li et al. BMC CANCER
- BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer
- (2018) Chun Gong et al. CLINICAL CANCER RESEARCH
- Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
- (2018) Svetlana Semina et al. MOLECULES
- Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
- (2018) Alacoque L. Browne et al. ONCOGENE
- Estrogen Receptor‐Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance
- (2018) Adam M. Brufsky et al. ONCOLOGIST
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
- (2018) Hitisha K. Patel et al. PHARMACOLOGY & THERAPEUTICS
- Communication between genomic and non-genomic signaling events coordinate steroid hormone actions
- (2018) Sandi R. Wilkenfeld et al. STEROIDS
- Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
- (2018) Rasmus Siersbæk et al. GENES & DEVELOPMENT
- Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
- (2018) Małgorzata Szostakowska et al. BREAST CANCER RESEARCH AND TREATMENT
- ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
- (2018) Xiao‐Han Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations
- (2018) Liqun Yu et al. CANCER LETTERS
- Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications
- (2017) Jean-Francois Arnal et al. PHYSIOLOGICAL REVIEWS
- Targeting the mTOR pathway in breast cancer
- (2017) Jia Liu et al. TUMOR BIOLOGY
- Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
- (2017) Lesley-Ann Martin et al. Nature Communications
- FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
- (2017) Lukasz Turczyk et al. NEOPLASIA
- The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System
- (2016) Sara Menazza et al. CIRCULATION RESEARCH
- Targeting Estrogen Receptor (ER) Mutations for Treatment of Endocrine Therapy Resistance in Breast Cancer
- (2016) P.G. Alluri et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer
- (2016) Stéphanie Légaré et al. MOLECULAR ENDOCRINOLOGY
- Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
- (2016) A Harrod et al. ONCOGENE
- Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
- (2016) Sean W Fanning et al. eLife
- Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects
- (2015) Yoko Omoto et al. CANCER SCIENCE
- The novel role of miRNAs for tamoxifen resistance in human breast cancer
- (2015) Wenwen Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
- (2015) Donald P. McDonnell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells
- (2015) Zhike Chen et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The role of the insulin-like growth factor-1 system in breast cancer
- (2015) Panagiotis F Christopoulos et al. Molecular Cancer
- Intratumoural inflammation and endocrine resistance in breast cancer
- (2014) Jill I Murray et al. ENDOCRINE-RELATED CANCER
- Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)
- (2014) RUBÍ VIEDMA-RODRÍGUEZ et al. ONCOLOGY REPORTS
- Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
- (2014) Bo Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
- (2014) Elisavet Paplomata et al. Therapeutic Advances in Medical Oncology
- Everolimus in Postmenopausal, Hormone Receptor-Positive Advanced Breast Cancer: Summary and Results of an Austrian Expert Panel Discussion
- (2013) Michael Gnant et al. Breast Care
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells
- (2013) Lacey M. Litchfield et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Estrogen receptor beta in breast cancer
- (2013) Lars-Arne Haldosén et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Estrogen synthesis and signaling pathways during aging: from periphery to brain
- (2013) Jie Cui et al. TRENDS IN MOLECULAR MEDICINE
- mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions
- (2012) C. Villarreal-Garza et al. ANNALS OF ONCOLOGY
- Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer
- (2012) Jing Peng et al. Anti-Cancer Agents in Medicinal Chemistry
- Tamoxifen Resistance in Breast Cancer
- (2012) Min-Sun Chang Biomolecules & Therapeutics
- The Function of Steroid Receptor Coactivator-1 in Normal Tissues and Cancer
- (2012) Claire A. Walsh et al. International Journal of Biological Sciences
- Biological mechanisms and clinical implications of endocrine resistance in breast cancer
- (2011) Mario Giuliano et al. BREAST
- Mechanisms of FGFR3 actions in endocrine resistant breast cancer
- (2011) D.C. Tomlinson et al. INTERNATIONAL JOURNAL OF CANCER
- Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes
- (2010) Madhu S. Singh et al. BREAST
- Antiestrogens Induce Transforming Growth Factor -Mediated Immunosuppression in Breast Cancer
- (2010) C. M. Joffroy et al. CANCER RESEARCH
- Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line
- (2010) S. Karmakar et al. ENDOCRINE-RELATED CANCER
- Ligand-Independent ER Activation
- (2010) A. M. VanHook Science Signaling
- Steroid signaling activation and intracellular localization of sex steroid receptors
- (2010) Tiziana Giraldi et al. Journal of Cell Communication and Signaling
- Breast Cancer, Estrogen Receptor and Ligands
- (2009) Zhenlin Bai et al. ARCHIV DER PHARMAZIE
- Cell proliferation regulated by estradiol receptor: Therapeutic implications
- (2009) Gabriella Castoria et al. STEROIDS
- Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer
- (2008) Marinella Zilli et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- p21 and p27: roles in carcinogenesis and drug resistance
- (2008) Abde M. Abukhdeir et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells
- (2008) Qingbo Su et al. ONCOLOGY
- Estrogen signaling pathway and hormonal therapy
- (2008) Shin-ichi Hayashi et al. Breast Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started